This MedLibrary.org supplementary page on Renovascular hypertension is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
| Renovascular hypertension Classification and external resources |
|
| ICD-10 | I15.0 |
|---|---|
| ICD-9 | 403 |
| MedlinePlus | 000204 |
| eMedicine | med/2006 |
| MeSH | D006978 |
Renovascular hypertension (or "renal hypertension") is a syndrome which consists of high blood pressure caused by narrowing of the arteries supplying the kidneys (renal artery stenosis). It is a form of secondary hypertension - a form of hypertension whose cause is identifiable.
Contents |
Diagnosis and presentation
Techniques have been developed to diagnose renal hypertension using digital image processing of radiographs. Treatment may involve angioplasty and stenting of the renal arteries. The syndrome may be related to other diseases of the epithelium.
Suggestive clinical features include onset of hypertension <30 or >50 years of age, abdominal or femoral bruits, hypokalemic alkalosis, moderate to severe retinopathy, acute onset of hypertension or malignant hypertension, and hypertension resistant to medical therapy.
The "gold standard" in diagnosis of renal artery stenosis is conventional arteriography. Magnetic resonance angiography (MRA) is used in many centers, especially among pts with renal insufficiency at higher risk for contrast nephropathy. MRA may overestimate the severity of stenosis relative to angiography. In pts with normal renal function and hypertension, the captopril (or enalaprilat) renogram may be used. Lateralization of renal function [accentuation of the difference between affected and unaffected (or "less affected") sides] is suggestive of significant vascular disease. Test results may be falsely negative in the presence of bilateral disease.
Treatment
Renal hypoperfusion activates renin-angiotensin-aldosterone (RAA) axis; ACE inhibitors and ARB classes of antihypertensives are contraindicated as they might compromise the renal function especially if the Stenosis is bilateral. Nitroprusside, labetalol, or calcium antagonists are generally effective in lowering bp acutely, although inhibitors of the RAA axis [e.g., ACE inhibitors, angiotensin II receptor blockers (ARBs)] are most effective long-term treatment, if disease is not bilateral.
Surgical revascularization appears to be superior for ostial lesions characteristic of atherosclerosis. The relative efficacy of surgery compared with angioplasty (especially with stenting) for fibromuscular dysplasia or for nonocclusive, nonostial atherosclerotic disease is unclear. Angioplasty (with or without stenting) tends to be most effective for mid-vessel or more distal lesions. No studies have adequately compared revascularization with medical therapy. ACE inhibitors or ARBs are ideal agents for hypertension associated with renal artery stenosis, except in pts with bilateral disease (see "Ischemic Nephropathy," below) or disease in a solitary kidney (including an allograft).
Source
- Harrison's Manual of Medicine: Renovascular Disease - Renal Artery Stenosis
See also
External links
|
|||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
 |
This disease article is a stub. You can help Wikipedia by expanding it. |
Wikipedia content modification information:
- This page was last modified on 9 August 2008, at 23:54.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Renovascular hypertension".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.